Project ID: D2016-29 IP Status: PCT patent application filed Invention Description and Novelty: “Thin” molecules offer stronger binding to PPAR and include greater lipid burning and glucose lowering properties. Applications: Dyslipidemia, obesity and type II diabetes Value propositions: • B.....
[更多]
Customized page headerCustomized faculty page header and templateFaculty and personal page display with ?Faces? display of the organizationTools to let faculty and other unit members maintain web pages via formsCustomized and shared newsCustomized and shared administrative mattersRepository for fina.....
[更多]
Platelet accumulation at sites of vascular injury, even if unintentionally introduced during surgical procedures, is a life-threatening event, for which there are currently no highly-specific treatments. Current drugs dampen platelets or block their ability to form a thrombus, but since they block p.....
[更多]
Membrane proteins (MP) mediate many of the cell’s fundamental processes and MPs are embedded in the cell’s membrane lipid bilayer. Currently, MPs are targets for about 60% of therapeutic drugs in use. However, MPs are very difficult to manipulate and study because they require both an aqueous enviro.....
[更多]
Shih-Fu Chang, Ph.D.
[更多]
| |< <- | [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] | -> >| |
